Koers Hypertension Diagnostics, Inc. Other OTC
Aandelen
HDII
US44914V1044
Geavanceerde medische apparatuur & technologie
Omzet 2017 | 3,68 mln. 3,39 mln. | Omzet 2018 | 3,79 mln. 3,49 mln. | Marktkapitalisatie | 92,08K 84,79K |
---|---|---|---|---|---|
Nettowinst (verlies) 2017 | - 0 | Nettowinst (verlies) 2018 | - 0 | EV/omzet 2017 | 1,15 x |
Nettoschuld 2017 | 4,13 mln. 3,81 mln. | Nettoschuld 2018 | 4,6 mln. 4,23 mln. | EV/omzet 2018 | 1,24 x |
K/w-verhouding 2017 |
-0,28
x | K/w-verhouding 2018 |
-0,54
x | Werknemers | - |
Dividendrendement 2017 * |
-
| Dividendrendement 2018 |
-
| Vrij verhandelbaar | 100% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Liangjian Peng
CEO | Chief Executive Officer | - | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Liangjian Peng
CEO | Chief Executive Officer | - | - |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+12,50% | 229 mld. | |
+14,52% | 195 mld. | |
+17,51% | 142 mld. | |
+28,96% | 109 mld. | |
+3,27% | 64,85 mld. | |
+18,16% | 54,33 mld. | |
+7,63% | 52,09 mld. | |
+10,95% | 45,15 mld. | |
+5,10% | 37,39 mld. |